Study summary
Immunotherapy worked better with chemotherapy than alone in advanced penile cancer
60.7% vs 16.7%had tumors shrink, immunotherapy with vs without chemotherapy
What was tested
A pooled look at 12 groups of men with advanced penile cancer given immune checkpoint drugs, alone or with chemotherapy.
What they found
- Tumors shrank in 60.7% when immunotherapy was combined with chemotherapy, against 16.7% with immunotherapy alone.
- At 12 months, about 80% were alive.
- About 14% had serious immune-related side effects.
What it means
Supports combining immunotherapy with chemotherapy in trials. Evidence is still from small, mostly non-randomized studies.
Last reviewed 2026-11-14 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.